上腺素使阿尔茨海默病相关的原纤维素和纤维素不稳定:一项计算研究
相关实验视频
Updated: Sep 19, 2025
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.5K
Jiaxing Tang1, Dushuo Feng2, Feng Wang1
1School of Physical Education, Xiangnan University, 889 Chenzhou Avenue, Chenzhou 423000, People's Republic of China.
Physical chemistry chemical physics : PCCP
|June 17, 2025
概括
发现上腺素 (上腺素) 可以破坏与阿尔茨海默病相关的蛋白聚合物的稳定. 通过运动刺激的这种分子,通过破坏有毒的结构,可以提供新的治疗策略.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默氏病 (AD) 的特征是由高酸化的蛋白形成的神经纤维状 (NFTs).
- 抑制tau聚合是一种潜在的AD治疗策略.
- 已知上腺素 (上腺素) 在体外抑制聚,但其与的原子级相互作用尚不清楚.
研究的目的:
- 调查上腺素 (EP) 对与AD相关的原纤维和纤维的影响的原子洞察力.
- 阐明EP影响tau聚合和结构的分子机制.
主要方法:
- 在tau R3-R4原纤维和纤维上进行了全原子分子动力学 (MD) 模拟.
- 与上腺素分子和没有上腺素分子进行了模拟.
- 使用绑定分析来确定EP与tau聚合物的相互作用模式.
主要成果:
- EP增加了原纤维的结构不稳定性和灵活性,诱导了β-sheet-to-coil转换.
- EP重塑了关键的盐桥 (K353-D358),这对原纤维的稳定性至关重要.
- EP会破坏纤维的稳定,并可能逆转它们的液态固态相变 (LSPT).
结论:
- 上腺素通过各种力量与tau聚合物相互作用,包括疏水性,H结合,π-π堆叠和-π相互作用.
- EP与原纤维素和纤维素的独特结合方式表明了不同的效应.
- 这些发现为设计阿尔茨海默病候选药物和运动疗法提供了洞察力.
相关概念视频
01:26Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
03:03Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K